Gregory C. Ireton

Infectious Disease Research Institute — United States

Medicine · Health Sciences

21h-index3.6kcitations34works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(12), Mycobacterium research and diagnosis(10), Biochemical and Molecular Research(6), Immune Response and Inflammation(5), Enzyme Structure and Function(5)

Publications34 total

Identification of Novel Antigens Recognized by Serum Antibodies in Bovine Tuberculosis
Clinical and Vaccine Immunology·2017· 22 citedOpen Access
Comparison of Point-of-Care Tests for the Rapid Diagnosis of Visceral Leishmaniasis in East African Patients
American Journal of Tropical Medicine and Hygiene·2014· 45 citedOpen Access
Immune Subdominant Antigens as Vaccine Candidates against <i>Mycobacterium tuberculosis</i>
The Journal of Immunology·2014· 44 citedOpen Access
The ID93 Tuberculosis Vaccine Candidate Does Not Induce Sensitivity to Purified Protein Derivative
Clinical and Vaccine Immunology·2014· 18 citedOpen Access
Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis
Tuberculosis·2013· 11 citedOpen Access
Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle
Vaccine·2013· 16 citedOpen Access
Adjuvants containing natural and synthetic Toll-like receptor 4 ligands
Expert Review of Vaccines·2013· 30 cited
Clinical Research and Development of Tuberculosis Diagnostics: Moving From Silos to Synergy
The Journal of Infectious Diseases·2012· 39 citedOpen Access
Clinical Research and Development ofTuberculosis Diagnostics: Moving From Silos toSynergy
2012
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate
Vaccine·2011· 67 cited
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant <i>Mycobacterium tuberculosis</i>
Science Translational Medicine·2010· 301 citedOpen Access
Identification of<i>Mycobacterium tuberculosis</i>Antigens of High Serodiagnostic Value
Clinical and Vaccine Immunology·2010· 68 citedOpen Access
Synthetic and Natural TLR4 Agonists as Safe and Effective Vaccine Adjuvants
Sub-cellular biochemistry/Subcellular biochemistry·2010· 65 cited
The role of IL-17 in the protective immune response to Mycobacterium tuberculosis (44.18)
The Journal of Immunology·2009
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
Vaccine·2009· 91 citedOpen Access
Identification of Human T Cell Antigens for the Development of Vaccines against <i>Mycobacterium tuberculosis</i>
The Journal of Immunology·2008· 169 citedOpen Access
Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy
Protein Engineering Design and Selection·2004· 66 citedOpen Access
Microseed matrix screening to improve crystals of yeast cytosine deaminase. Erratum
Acta Crystallographica Section D Biological Crystallography·2004· 1 citedOpen Access
Microseed matrix screening to improve crystals of yeast cytosine deaminase
Acta Crystallographica Section D Biological Crystallography·2004· 79 cited
Design of a Novel Globular Protein Fold with Atomic-Level Accuracy
Science·2003· 1.7k cited
page 1 of 2Next →

Frequent Co-authors

Steven G. Reed(13), Rhea N. Coler(8), Susan L. Baldwin(7), Margaret E. Black(7), Barry Stoddard(7), Barry Stoddard(6), Lance Stewart(5), James J. Champoux(5), Sylvie Bertholet(4), Thomas S. Vedvick(4), Maria Kahn(3), Sheri D. Mahan(3), Brian Kuhlman(2), Gautam Dantas(2), Gabriele Varani(2), Hillarie Plessner Windish(2), Ian M. Orme(2), Leon Parker(2), Javan Esfandiari(2), Konstantin P. Lyashchenko(2)